[Sweden can contribute to safer drug assessment].
Strandberg
Kjell
K
kjell.strandberg@ksab.nu
D016907:Adverse Drug Reaction Reporting Systems; D003362:Cost-Benefit Analysis; D017277:Drug Approval; D016527:Drug Costs; D004345:Drug Industry; D004335:Drug and Narcotic Control; D006801:Humans; D007391:International Cooperation; D017891:Pharmacoepidemiology; D011785:Quality Assurance, Health Care; D012042:Registries; D018570:Risk Assessment; D012449:Safety; D013548:Sweden